Ads
related to: b cell
Search results
IGM Biosciences stock surges as Biogen's deal for HI-Bio is seen as a positive By Investing.com
Investing.com· 56 minutes agoIGM Biosciences stock surges as Biogen's deal for HI-Bio is seen as a positive
Is CRISPR Therapeutics a Millionaire Maker?
Motley Fool via Yahoo Finance· 5 hours agoThe company also has other high-impact clinical programs in later stages of development which are intended to treat conditions like renal cell carcinoma,...
Study finds tyrosine kinase Csk promotes germinal center B cell survival and affinity maturation
Medical Xpress· 2 days agoB cells, specialized cells in the immune system that recognize and "remember" foreign factors like bacteria, mature in the germinal center (GC) of immunity-related organs such as the spleen ...
A boost for HIV vaccine research: Studies present comprehensive platform for validating next steps
Medical Xpress· 1 day agoThe ultimate goal of GT immunization is to coach B cells into producing broadly neutralizing antibodies (bnAbs) capable of binding to conserved sites on HIV Env, which seldom change despite ...
Selective haematological cancer eradication with preserved haematopoiesis - Nature
Nature· 11 hours agoAn antibody–drug conjugate that targets the pan-haematopoietic marker CD45 combined with transplanted stem cells engineered to be shielded from it can eradicate leukaemic cells while preserving haematopoiesis.
Bristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration...
Morningstar· 7 days agoBristol Myers Squibb’s CAR T Cell Therapy Breyanzi Approved by the U.S. Food and Drug Administration for Relapsed or Refractory Follicular Lymphoma 95.7% of patients responded to Breyanzi in the TRANSCEND FL trial Breyanzi provided sustained clinical
Cell types and molecules usually associated with autoimmune diseases found to be normal components...
Medical Xpress· 5 days agoThe study is published in Nature. The authors used a combination of spatial transcriptomics and...
Q1 2024 Exscientia PLC Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 14 hours agoAnd for the first time announcing our plans for our MALT1 inhibitor, XS73565 or 565 as a potential treatment for B-cell lymphomas, including chronic lymphocytic ...
Breaking through the concept barrier to develop broad-spectrum antiviral counter-measures - Nature...
Nature· 2 days agoViruses are small infectious agents that can propagate in the living cells of humans, animals, plants, bacteria and fungi. To date, more than 200 human-infecting viruses have been reported, ...
ImmPACT Bio to Present New Preclinical Data for CD19/CD20 Bispecific CAR-T Cell Therapy in Multiple...
FOX 23 News Albany· 1 day agoImmPACT Bio USA Inc. (ImmPACT Bio), a clinical-stage biopharmaceutical company developing a new generation of cellular therapies that have the potential to bring transformational benefits to ...
